Skip Navigation
Skip to contents

JLC : Journal of Liver Cancer

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > J Liver Cancer > Volume 16(2); 2016 > Article
Case Report A Case of Achieving Complete Remission with Stereotactic Body Radiation Therapy in Patients with Hepatocellular Carcinoma with Macrovascular Invasion after Repeated Transarerial Chemoembolization
Sang Youn Hwang1, Seon-Mi Lee1, Jong Woo Im1, Ki Jeong Jeon1, Sang Bu Ahn2, Eun Kyeong Ji2, Jin-Young Park2, Cheol-Won Choi Choi3, Gwang-Mo Yang3
Journal of Liver Cancer 2016;16(2):123-128
DOI: https://doi.org/10.17998/jlc.16.2.123
Published online: September 30, 2016
1Departments of Internal Medicine, Dongnam Institute of Radiological and Medical Sciences,Busan, Korea
2Departments of Radiology, Dongnam Institute of Radiological and Medical Sciences,Busan, Korea
3Departments of Radiation Oncology, Dongnam Institute of Radiological and Medical Sciences,Busan, Korea
Corresponding author:  Sang Youn Hwang,
Email: mongmani@hanmail.net
  • 1,116 Views
  • 6 Download
  • 0 Crossref
  • 0 Scopus

Transarterial chemoembolization (TACE) is the worldwide procedure performed for patients with various stage hepatoceullar carcinoma (HCC), but is not yet considered as curative treatment because of relatively high local recurrence rate. Moreover, many clinicians frequently experience treatment failure (incomplete necrosis or stage progression etc.) after repeated TACE, but no clear guidelines have been recommended about salvage treatment modalities for this situation. Recently, studies for combination of radiation therapy and TACE for HCC with TACE refractoriness have been tried and reported better therapeutic efficacy. Based on above suggestions, we herein offer our experience of a patient with macrovascular invasion developed after repeated TACE that achieve complete remission by stereotactic body radiation therapy. Further study, maybe regarding a combination of locoregional and systemic therapy, is necessary on how to manage HCC patients with TACE refractoriness.


JLC : Journal of Liver Cancer